IreneKuterMDDPHIL

PubMed

• Adjuvant trastuzumab and vinorelbine for early-stage HER2+ breast cancer.
  Shannon McLaughlin, Erika Nakajima, Yael Bar, Jennifer A Hutchinson, Jennifer Shin, Beverly Moy, Steven J Isakoff, Aditya Bardia, Irene Kuter, Laura M Spring> ;Therapeutic Advances in Medical Oncology. 2023 Jan 1
• 5 citations
  Pilot study to assess prolonged overnight fasting in breast cancer survivors (longfast).
  Elizabeth O'Donnell, Yael Shapiro, Amy Comander, Steven Isakoff, Beverly Moy, Laura Spring, Seth Wander, Irene Kuter, Jennifer Shin, Michelle Specht, Chryssanthi Kourn...> ;Breast Cancer Research and Treatment. 2022 Jun 1
• 2 citations
  Immunogenicity of SARS-CoV-2 vaccines in patients with breast cancer.
  Elyssa Denault, Erika Nakajima, Vivek Naranbhai, Jennifer A Hutchinson, Lindsey Mortensen, Elizabeth Neihoff, Caroline Barabell, Amy Comander, Dejan Juric, Irene Kuter...> ;Therapeutic Advances in Medical Oncology. 2022 Jan 1
• 14 citations
  A Randomized Phase II Study of Anti-CSF-1 Monoclonal Antibody Lacnotuzumab (MCS110) Combined with Gemcitabine and Carboplatin in Advanced Triple Negative Breast Cancer
  Sherko Kuemmel, Mario Campone, Delphine Loirat, Rafael López, J. Thaddeus Beck, Michelino De Laurentiis, Seock-Ah Im, Sung Bae Kim, Ava Kwong, Guenther G. Steger, Esth...> ;Clinical Cancer Research. 2021 Oct 6
• 36 citations
  Clinical Outcomes With Abemaciclib After Prior CDK4/6 Inhibitor Progression in Breast Cancer: A Multicenter Experience.
  Seth A. Wander, Hyo S. Han, Mark L. Zangardi, Andrzej Niemierko, Veronica Mariotti, Leslie S L Kim, Jing Xi, Apurva Pandey, Siobhan Dunne, Azadeh Nasrazadani, Avinash ...> ;Journal of the National Comprehensive Cancer Network. 2021 Mar 24
• 491 citations
  Long-term Clinical Outcomes and Biomarker Analyses of Atezolizumab Therapy for Patients With Metastatic Triple-Negative Breast Cancer: A Phase 1 Study.
  Leisha A. Emens, Cristina Cruz, Joseph Paul Eder, Fadi Braiteh, Cathie Chung, Sara M. Tolaney, Irene Kuter, Rita Nanda, Philippe A. Cassier, Jean Pierre Delord, Michae...> ;JAMA Oncology. 2019 Jan 1
• 67 citations
  Major Cardiac Events and the Value of Echocardiographic Evaluation in Patients Receiving Anthracycline-Based Chemotherapy.
  Lin Wang, Timothy C. Tan, Elkan F. Halpern, Tomas G. Neilan, Sanjeev A. Francis, Michael H. Picard, Hong-wen Fei M.D., Ephraim P. Hochberg, Jeremy S. Abramson, Arthur ...> ;The American Journal of Cardiology. 2015 Aug 1
• 105 citations
  Longitudinal Changes in Multiple Biomarkers Are Associated with Cardiotoxicity in Breast Cancer Patients Treated with Doxorubicin, Taxanes, and Trastuzumab
  Mary E. Putt, Virginia S. Hahn, James L. Januzzi, Heloisa Sawaya, Igal A. Sebag, Juan Carlos Plana, Michael H. Picard, Joseph R. Carver, Elkan F. Halpern, Irene Kuter,...> ;Clinical Chemistry. 2015 Sep 1
• 49 citations
  Time Trends of Left Ventricular Ejection Fraction and Myocardial Deformation Indices in a Cohort of Women with Breast Cancer Treated with Anthracyclines, Taxanes, and ...
  Timothy C. Tan, Souhila Bouras, Heloisa Sawaya, Igal A. Sebag, Victor Cohen, Michael H. Picard, Jonathan J. Passeri, Irene Kuter, Marielle Scherrer-Crosbie> ;Journal of the American Society of Echocardiography. 2015 May 1
• 13 citations
  Long-Term Follow-Up After Preoperative Trastuzumab and Chemotherapy for HER2-Overexpressing Breast Cancer
  Erica L. Mayer, Adrienne B. Gropper, Lyndsay Harris, J. Gold, Leroy M. Parker, Irene Kuter, Steven E. Come, Julie Najita, Hao Guo, Eric P. Winer, Harold J. Burstein> ;Clinical Breast Cancer. 2015 Feb 1
• 50 citations
  A Good Drug Made Better: The Fulvestrant Dose-Response Story
  John F.R. Robertson, Justin P.O. Lindemann, Sally Garnett, Elizabeth Anderson, Robert Ian Nicholson, Irene Kuter, Julia Margaret Wendy Gee> ;Clinical Breast Cancer. 2014 Dec 1
• 15 citations
  Differences in the Transcriptional Response to Fulvestrant and Estrogen Deprivation in ER-Positive Breast Cancer
  Neill Patani, Anita K. Dunbier, Helen Anderson, Zara Ghazoui, Ricardo Ribas, Elizabeth Anderson, Qiong Gao, Roger A'Hern, Alan Mackay, Justin P.O. Lindemann, Robert We...> ;Clinical Cancer Research. 2014 Aug 1
• 25 citations
  Development and Validation of a Gene Expression Score That Predicts Response to Fulvestrant in Breast Cancer Patients
  Steen Knudsen, Thomas Jensen, Anker Jon Hansen, Wiktor Mazin, Justin P.O. Lindemann, Irene Kuter, Naomi Laing, Elizabeth Anderson> ;Plos One. 2014 Feb 5
• 359 citations
  Early increases in multiple biomarkers predict subsequent cardiotoxicity in patients with breast cancer treated with doxorubicin, taxanes, and trastuzumab.
  Bonnie Ky, Mary E. Putt, Heloisa Sawaya, Benjamin French, James L. Januzzi, Igal A. Sebag, Juan Carlos Plana, Victor Cohen, Jose Banchs, Joseph R. Carver, Susan E. Wie...> ;Journal of the American College of Cardiology. 2014 Mar 4
• 5 citations
  Circulating tumor cells as predictors of response and failure in breast cancer patients treated with preoperative chemotherapy.
  Rimoun Boutrus, Rita Abi Raad, Irene Kuter, Marek Ancukiewicz, Lisa Roberts, Natalie A. Solomon, Taylor Ngo, Heather Borick, Paula D. Ryan, Beverly Moy, Michele A. Gad...> ;The International Journal of Biological Markers. 2013 Apr 23
• 531 citations
  Assessment of Echocardiography and Biomarkers for the Extended Prediction of Cardiotoxicity in Patients Treated With Anthracyclines, Taxanes, and Trastuzumab
  Heloisa Sawaya, Igal A. Sebag, Juan Carlos Plana, James L. Januzzi, Bonnie Ky, Timothy C. Tan, Victor Cohen, Jose Banchs, Joseph R. Carver, Susan E. Wiegers, Randolph ...> ;Circulation. Cardiovascular Imaging. 2012 Sep 1
• 71 citations
  Dose-dependent change in biomarkers during neoadjuvant endocrine therapy with fulvestrant: results from NEWEST, a randomized Phase II study
  Irene Kuter, Julia Margaret Wendy Gee, Roberto Hegg, Christian F. Singer, Rajendra A. Badwe, Elizabeth S. Lowe, Ugochi Emeribe, Elizabeth Anderson, Francisco Sapunar, ...> ;Breast Cancer Research and Treatment. 2012 Jan 28
• 447 citations
  Early detection and prediction of cardiotoxicity in chemotherapy-treated patients.
  Heloisa Sawaya, Igal A. Sebag, Juan Carlos Plana, James L. Januzzi, Bonnie Ky, Victor Cohen, Sucheta Gosavi, Joseph R. Carver, Susan E. Wiegers, Randolph P. Martin, Mi...> ;The American Journal of Cardiology. 2011 May 1
• Comparison of methods for detection of fulvestrant-induced changes in breast tumor estrogen and progesterone receptor expression in a neoadjuvant trial (NEWEST).
  Kuter I, Anderson E, Emeribe U, Finlay P, Nicholson R, Gee J> ;J. Clin. Oncol.. 2009-05-20
• Tolerability and efficacy of 500 mg fulvestrant in postmenopausal women with estrogen receptor (ER)+ advanced breast cancer.
  Come SE, Parker LM, Wulf G, Kuter I, Ryan PD, Tkaczuk K, Borges V, Kasper H, Gelman R, Winer EP> ;J. Clin. Oncol.. 2009-05-20
• 109 citations
  VEGF as a marker for outcome among advanced breast cancer patients receiving anti-VEGF therapy with bevacizumab and vinorelbine chemotherapy.
  Harold J. Burstein, Yi Chen, Leroy M. Parker, Jennifer Savoie, Jerry Younger, Irene Kuter, Paula D. Ryan, Judy Garber, Helen H.W. Chen, Susana M. Campos, Lawrence N. S...> ;Clinical Cancer Research. 2008 Dec 1
• 132 citations
  Survival in patients with brain metastases from breast cancer: the importance of HER-2 status.
  April F. Eichler, Irene Kuter, Paula D. Ryan, Lidia Schapira, Jerry Younger, John W. Henson> ;Cancer. 2008 Jun 1
• Pharmacokinetic profile of fulvestrant 500 mg vs 250 mg: Results from the NEWEST study.
  Kuter I, Sapunar F, McCormack P> ;J. Clin. Oncol.. 2008-05-20
• 50 citations
  Flare Response in 18F-Fluoride Ion PET Bone Scanning
  Andrew A Wade, James A. Scott, Irene Kuter, Alan J. Fischman> ;AJR. American Journal of Roentgenology. 2006 Jun 1
• 35 citations
  Prospective evaluation of concurrent paclitaxel and radiation therapy after adjuvant doxorubicin and cyclophosphamide chemotherapy for Stage II or III breast cancer.
  Harold J. Burstein, Jennifer R. Bellon, Sharon Galper, Hsiao-Ming Lu, Irene Kuter, Alphonse G. Taghian, Julia Wong, Rebecca Gelman, Craig A. Bunnell, Leroy M. Parker, ...> ;International Journal of Radiation Oncology, Biology, Physics. 2006 Feb 1
• Join now to see all

Lectures

• Internal Medicine: Comprehensive Board Review and Update 
  Harvard Medical School ,Department Of Continuing Education, Cambridge, Massachusetts - 6/10/2013